SELLAS Life Sciences SLS
NASDAQ SLS
$12.21 +0.70 (+6.08%)
As of: Sep 30, 2026 · 2:59 PM EDT

SELLAS Life Sciences (SLS) Total Non-Current Liabilities (2010 - 2022)

Updated

SELLAS Life Sciences (SLS) posted Total Non-Current Liabilities of $16.09 million for Q4 2022, up 185.7% from $5.63 million a year earlier and up 21.6% from the prior quarter.

Analysis

SELLAS Life Sciences (SLS) Total Non-Current Liabilities (2010 - 2022) Analysis & Trends

Since Q4 2010, SELLAS Life Sciences has reported Total Non-Current Liabilities for 47 quarters.

  • Annual Total Non-Current Liabilities shows a five-year compound annual growth rate of -11.8% (FY2017 to FY2022).
  • In prior years, SELLAS Life Sciences' Total Non-Current Liabilities was $5.63 million in FY2021 (-58.1%), $13.46 million in FY2020 (+140.1%), $5.6 million in FY2019 (-23.7%) and $7.34 million in FY2018 (-75.7%).
  • Quarterly Total Non-Current Liabilities has run from a low of $3.91 million in Q1 2020 to a high of $30.1 million in Q1 2018 over five years.
  • On a year-over-year basis, Total Non-Current Liabilities has increased in each of the last four quarters, with growth averaging 77.2% over the last eight quarters.
  • The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q4 2022, with growth of 185.7%; the weakest was Q2 2019, with a decline of 79.9%.
  • According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $13.23 million (Q3 2022), $12.97 million (Q2 2022) and $17.11 million (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 105.99 Bn
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn 106.45 Bn
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn 80.25 Bn
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 48.34 Bn
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn -967.00 Mn
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 81.11 Bn
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn 36.04 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 100.86 Bn
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn 5.92 Bn
10 SELLAS Life Sciences 2.32 Bn 2.32 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 16.09 Mn
Sep 30, 2022 13.23 Mn
Jun 30, 2022 12.97 Mn
Mar 31, 2022 17.11 Mn
Dec 31, 2021 5.63 Mn
Sep 30, 2021 6.31 Mn
Jun 30, 2021 5.31 Mn
Mar 31, 2021 7.07 Mn
Dec 31, 2020 13.46 Mn
Sep 30, 2020 5.38 Mn
Jun 30, 2020 5.54 Mn
Mar 31, 2020 3.91 Mn
Dec 31, 2019 5.60 Mn
Sep 30, 2019 6.01 Mn
Jun 30, 2019 5.89 Mn
Mar 31, 2019 7.26 Mn
Dec 31, 2018 7.34 Mn
Sep 30, 2018 14.69 Mn
Jun 30, 2018 29.30 Mn
Mar 31, 2018 30.10 Mn
API Access

SELLAS Life Sciences Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=SLS&period=max&api_key=YOUR_API_KEY